Obinutuzumab
Information about Obinutuzumab
Obinutuzumab uses
Obinutuzumab is used in the treatment of Blood cancer (Chronic lymphocytic leukemia).
How obinutuzumab works
Obinutuzumab works by recognizing and attaching to specific proteins (namely CD20) on leukemia cells and some healthy blood cells. It destroys leukemia cells directly or with the help of the immune system.
Common side effects of obinutuzumab
Nasopharyngitis (inflammation of the throat and nasal passages), Upper respiratory tract infection, Rash, Flu, Dermatitis, Bronchitis (inflammation of the airways), Eczema, Swelling of lymph nodes, Oropharyngeal pain
Available Medicine for Obinutuzumab
Expert advice for Obinutuzumab
- After starting the treatment with Obinutuzumab, you may be at risk of infection; so, try to avoid crowds or people with colds, and report fever or any other signs of infection immediately to your doctor.
- Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor and eat small, frequent meals.
- Your doctor may monitor your blood counts before you start taking this medicine and regularly throughout your treatment.
- Avoid taking any other vaccines without consulting your doctor.
- It can make you feel dizzy for the first few days. Rise slowly if you have been sitting or lying down for a long time.
- Avoid breastfeeding while taking Obinutuzumab and for six months after its last dose.
- Women of childbearing potential should use effective contraception during and for six months after the treatment with this medicine.